Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Deborah Knobelman > Profile

Deborah Knobelman

Affiliations

  • President & Interim Ceo at Kronos Bio Inc. (KRON), 2025-06-20
  • Chief Financial Officer at Senti Biosciences Inc. (SNTI), 2024-02-02
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
KRON $0.87 24,838 $21,554.42 139,422 2025-06-05 Filing